# Air Products & Chemicals, Inc.: financial statements, quarterly

APD · NYSE · CIK 2969 · [Materials](/sectors/materials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/apd.md) · [Financials](/companies/apd/financials.md) · [Filings](/companies/apd/filings.md) · [Insiders](/companies/apd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/apd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,191 d](/filings/0000002969-25-000055.md) | [2,997](/filings/0000002969-25-000013.md) | [2,930](/filings/0000002969-25-000027.md) | [2,986](/filings/0000002969-25-000044.md) | [3,188 d](/filings/0000002969-25-000055.md) | [2,932](/filings/0000002969-26-000008.md) | [2,916](/filings/0000002969-26-000020.md) | [3,023](/filings/0000002969-26-000036.md) | [3,167 d](/filings/0000002969-25-000055.md) | [3,103](/filings/0000002969-26-000008.md) | [3,172](/filings/0000002969-26-000020.md) | [3,161](/filings/0000002969-26-000036.md) |
| Cost of revenue | $m | [2,207 d](/filings/0000002969-25-000055.md) | [2,067](/filings/0000002969-25-000013.md) | [1,992](/filings/0000002969-25-000027.md) | [2,006](/filings/0000002969-25-000044.md) | [2,104 d](/filings/0000002969-25-000055.md) | [2,017](/filings/0000002969-26-000008.md) | [2,054](/filings/0000002969-26-000020.md) | [2,040](/filings/0000002969-26-000036.md) | [2,146 d](/filings/0000002969-25-000055.md) | [2,108](/filings/0000002969-26-000008.md) | [2,184](/filings/0000002969-26-000020.md) | [2,125](/filings/0000002969-26-000036.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [24.7 d](/filings/0000002969-25-000055.md) | [25.7](/filings/0000002969-25-000013.md) | [25.4](/filings/0000002969-25-000027.md) | [27.0](/filings/0000002969-25-000044.md) | [22.1 d](/filings/0000002969-25-000055.md) | [22.0](/filings/0000002969-26-000008.md) | [22.9](/filings/0000002969-26-000020.md) | [24.1](/filings/0000002969-26-000036.md) | [27.3 d](/filings/0000002969-25-000055.md) | [20.4](/filings/0000002969-26-000008.md) | [21.6](/filings/0000002969-26-000020.md) | [21.5](/filings/0000002969-26-000036.md) |
| Selling, general and administrative | $m | [233 d](/filings/0000002969-25-000055.md) | [238](/filings/0000002969-25-000013.md) | [241](/filings/0000002969-25-000027.md) | [235](/filings/0000002969-25-000044.md) | [228 d](/filings/0000002969-25-000055.md) | [242](/filings/0000002969-26-000008.md) | [222](/filings/0000002969-26-000020.md) | [223](/filings/0000002969-26-000036.md) | [219 d](/filings/0000002969-25-000055.md) | [229](/filings/0000002969-26-000008.md) | [227](/filings/0000002969-26-000020.md) | [219](/filings/0000002969-26-000036.md) |
| Operating income | $m | [739 d](/filings/0000002969-25-000055.md) | [667](/filings/0000002969-25-000013.md) | [637](/filings/0000002969-25-000027.md) | [738](/filings/0000002969-25-000044.md) | [2,424 d](/filings/0000002969-25-000055.md) | [644](/filings/0000002969-26-000008.md) | [(2,328)](/filings/0000002969-26-000020.md) | [791](/filings/0000002969-26-000036.md) | [16.8 d](/filings/0000002969-25-000055.md) | [735](/filings/0000002969-26-000008.md) | [753](/filings/0000002969-26-000020.md) | [(2,097)](/filings/0000002969-26-000036.md) |
| Interest expense | $m | [48.0 d](/filings/0000002969-23-000047.md) | [53.5](/filings/0000002969-24-000010.md) | [59.9](/filings/0000002969-24-000026.md) | [55.7](/filings/0000002969-25-000044.md) | [49.7 d](/filings/0000002969-25-000055.md) | [42.6](/filings/0000002969-26-000008.md) | [42.2](/filings/0000002969-26-000020.md) | [61.4](/filings/0000002969-26-000036.md) | [67.8 d](/filings/0000002969-25-000055.md) | [54.5](/filings/0000002969-26-000008.md) | [49.5](/filings/0000002969-26-000020.md) | [49.4](/filings/0000002969-26-000036.md) |
| Income tax | $m | [154 d](/filings/0000002969-25-000055.md) | [135](/filings/0000002969-25-000013.md) | [131](/filings/0000002969-25-000027.md) | [141](/filings/0000002969-25-000044.md) | [538 d](/filings/0000002969-25-000055.md) | [141](/filings/0000002969-26-000008.md) | [(506)](/filings/0000002969-26-000020.md) | [160](/filings/0000002969-26-000036.md) | [111 d](/filings/0000002969-25-000055.md) | [159](/filings/0000002969-26-000008.md) | [159](/filings/0000002969-26-000020.md) | [(515)](/filings/0000002969-26-000036.md) |
| Net income | $m | [693 d](/filings/0000002969-25-000055.md) | [609](/filings/0000002969-25-000013.md) | [572](/filings/0000002969-25-000027.md) | [697](/filings/0000002969-25-000044.md) | [1,950 d](/filings/0000002969-25-000055.md) | [617](/filings/0000002969-26-000008.md) | [(1,731)](/filings/0000002969-26-000020.md) | [714](/filings/0000002969-26-000036.md) | [4.9 d](/filings/0000002969-25-000055.md) | [678](/filings/0000002969-26-000008.md) | [710](/filings/0000002969-26-000020.md) | [(1,441)](/filings/0000002969-26-000036.md) |
| Diluted EPS | $ per share | not reported | [2.73](/filings/0000002969-25-000013.md) | [2.57](/filings/0000002969-25-000027.md) | [3.13](/filings/0000002969-25-000044.md) | not reported | [2.77](/filings/0000002969-26-000008.md) | [(7.77)](/filings/0000002969-26-000020.md) | [3.20](/filings/0000002969-26-000036.md) | not reported | [3.04](/filings/0000002969-26-000008.md) | [3.19](/filings/0000002969-26-000020.md) | [(6.47)](/filings/0000002969-26-000036.md) |
| Basic EPS | $ per share | not reported | [2.74](/filings/0000002969-25-000013.md) | [2.57](/filings/0000002969-25-000027.md) | [3.13](/filings/0000002969-25-000044.md) | not reported | [2.77](/filings/0000002969-26-000008.md) | [(7.77)](/filings/0000002969-26-000020.md) | [3.20](/filings/0000002969-26-000036.md) | not reported | [3.04](/filings/0000002969-26-000008.md) | [3.19](/filings/0000002969-26-000020.md) | [(6.47)](/filings/0000002969-26-000036.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.6](/filings/0000002969-24-000056.md) | [2.0](/filings/0000002969-24-000010.md) | [2.5](/filings/0000002969-24-000026.md) | [2.4](/filings/0000002969-24-000043.md) | [3.0](/filings/0000002969-25-000055.md) | [1.8](/filings/0000002969-25-000013.md) | [1.5](/filings/0000002969-25-000027.md) | [2.3](/filings/0000002969-25-000044.md) | [1.9](/filings/0000002969-26-000036.md) | [1.0](/filings/0000002969-26-000008.md) | [1.0](/filings/0000002969-26-000020.md) | [1.0](/filings/0000002969-26-000036.md) |
| Current assets | $bn | [5.2](/filings/0000002969-24-000056.md) | [5.6](/filings/0000002969-24-000010.md) | [6.1](/filings/0000002969-24-000026.md) | [5.7](/filings/0000002969-24-000043.md) | [6.4](/filings/0000002969-25-000055.md) | [5.4](/filings/0000002969-25-000013.md) | [5.2](/filings/0000002969-25-000027.md) | [6.1](/filings/0000002969-25-000044.md) | [5.8](/filings/0000002969-26-000036.md) | [5.1](/filings/0000002969-26-000008.md) | [5.0](/filings/0000002969-26-000020.md) | [5.0](/filings/0000002969-26-000036.md) |
| Total assets | $bn | [32.0](/filings/0000002969-24-000056.md) | [34.1](/filings/0000002969-24-000010.md) | [35.9](/filings/0000002969-24-000026.md) | [37.0](/filings/0000002969-24-000043.md) | [39.6](/filings/0000002969-25-000055.md) | [40.0](/filings/0000002969-25-000013.md) | [38.9](/filings/0000002969-25-000027.md) | [41.7](/filings/0000002969-25-000044.md) | [41.1](/filings/0000002969-26-000036.md) | [41.2](/filings/0000002969-26-000008.md) | [41.6](/filings/0000002969-26-000020.md) | [40.4](/filings/0000002969-26-000036.md) |
| Current liabilities | $bn | [3.9](/filings/0000002969-24-000056.md) | [3.1](/filings/0000002969-24-000010.md) | [4.1](/filings/0000002969-24-000026.md) | [4.5](/filings/0000002969-24-000043.md) | [4.2](/filings/0000002969-25-000055.md) | [4.8](/filings/0000002969-25-000013.md) | [5.2](/filings/0000002969-25-000027.md) | [4.8](/filings/0000002969-25-000044.md) | [4.2](/filings/0000002969-26-000036.md) | [3.5](/filings/0000002969-26-000008.md) | [3.5](/filings/0000002969-26-000020.md) | [4.6](/filings/0000002969-26-000036.md) |
| Total liabilities | $bn | [16.3](/filings/0000002969-24-000056.md) | [18.0](/filings/0000002969-24-000010.md) | [19.6](/filings/0000002969-24-000026.md) | [20.3](/filings/0000002969-24-000043.md) | [20.9](/filings/0000002969-25-000055.md) | [21.3](/filings/0000002969-25-000013.md) | [22.1](/filings/0000002969-25-000027.md) | [23.9](/filings/0000002969-25-000044.md) | [23.7](/filings/0000002969-26-000036.md) | [23.4](/filings/0000002969-26-000008.md) | [23.5](/filings/0000002969-26-000020.md) | [23.8](/filings/0000002969-26-000036.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.3](/filings/0000002969-24-000056.md) | [0.0](/filings/0000002969-24-000010.md) | [0.2](/filings/0000002969-24-000026.md) | [0.2](/filings/0000002969-24-000043.md) | [0.1](/filings/0000002969-25-000055.md) | [0.1](/filings/0000002969-25-000013.md) | [0.8](/filings/0000002969-25-000027.md) | [0.5](/filings/0000002969-25-000044.md) | [0.0](/filings/0000002969-26-000036.md) | [0.1](/filings/0000002969-26-000008.md) | [0.3](/filings/0000002969-26-000020.md) | [0.1](/filings/0000002969-26-000036.md) |
| Shareholders' equity | $bn | [14.3](/filings/0000002969-24-000056.md) | [14.9](/filings/0000002969-24-000010.md) | [14.9](/filings/0000002969-24-000026.md) | [15.1](/filings/0000002969-24-000043.md) | [17.0](/filings/0000002969-25-000055.md) | [16.7](/filings/0000002969-25-000013.md) | [14.7](/filings/0000002969-25-000027.md) | [15.5](/filings/0000002969-25-000044.md) | [15.0](/filings/0000002969-26-000036.md) | [15.4](/filings/0000002969-26-000008.md) | [15.6](/filings/0000002969-26-000020.md) | [13.9](/filings/0000002969-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,002 d](/filings/0000002969-25-000055.md) | [627](/filings/0000002969-25-000013.md) | [802 d](/filings/0000002969-25-000027.md) | [1,261 d](/filings/0000002969-25-000044.md) | [957 d](/filings/0000002969-25-000055.md) | [812](/filings/0000002969-26-000008.md) | [328 d](/filings/0000002969-26-000020.md) | [856 d](/filings/0000002969-26-000036.md) | [1,261 d](/filings/0000002969-25-000055.md) | [901](/filings/0000002969-26-000008.md) | [1,104 d](/filings/0000002969-26-000020.md) | [1,305 d](/filings/0000002969-26-000036.md) |
| Capital expenditure | $m | [1,463 d](/filings/0000002969-25-000055.md) | [1,446](/filings/0000002969-25-000013.md) | [1,669 d](/filings/0000002969-25-000027.md) | [1,607 d](/filings/0000002969-25-000044.md) | [2,075 d](/filings/0000002969-25-000055.md) | [2,118](/filings/0000002969-26-000008.md) | [1,892 d](/filings/0000002969-26-000020.md) | [1,496 d](/filings/0000002969-26-000036.md) | [1,518 d](/filings/0000002969-25-000055.md) | [1,251](/filings/0000002969-26-000008.md) | [1,108 d](/filings/0000002969-26-000020.md) | [996 d](/filings/0000002969-26-000036.md) |
| Dividends paid | $m | [389 d](/filings/0000002969-25-000055.md) | [389](/filings/0000002969-25-000013.md) | [389 d](/filings/0000002969-25-000027.md) | [394 d](/filings/0000002969-25-000044.md) | [394 d](/filings/0000002969-25-000055.md) | [394](/filings/0000002969-26-000008.md) | [394 d](/filings/0000002969-26-000020.md) | [398 d](/filings/0000002969-26-000036.md) | [398 d](/filings/0000002969-25-000055.md) | [398](/filings/0000002969-26-000008.md) | [399 d](/filings/0000002969-26-000020.md) | [403 d](/filings/0000002969-26-000036.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [223](/filings/0000002969-24-000010.md) | [223](/filings/0000002969-24-000026.md) | [223](/filings/0000002969-24-000043.md) | [223](/filings/0000002969-25-000013.md) | [223](/filings/0000002969-25-000027.md) | [223](/filings/0000002969-25-000044.md) | [223](/filings/0000002969-26-000008.md) | [223](/filings/0000002969-26-000020.md) | [223](/filings/0000002969-26-000036.md) | [223](/filings/0000002969-26-000008.md) | [223](/filings/0000002969-26-000020.md) | [223](/filings/0000002969-26-000036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 222,685,530 at 2026-06-30, from the cover of the [10-Q filed 2026-07-30](/filings/0000002969-26-000036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.